Back to Results
First PageMeta Content
Lactams / Human sexuality / Pfizer / Piperazines / Pyrazolopyrimidines / Sildenafil / CGMP-specific phosphodiesterase type 5 / Erectile dysfunction / Phosphodiesterase / Organic chemistry / Chemistry / PDE5 inhibitors


The cost-utility of Viagra® in The Netherlands *Elly A. Stolk, M.Sc.1 Jan J. V Busschbach, Ph.D.1 Max Caffa, M.D.2
Add to Reading List

Document Date: 2010-07-20 09:36:51

Open Document

File Size: 201,13 KB

Share Result on Facebook

Company

Pfizer BV / Agency for the Evaluation / /

Country

Netherlands / /

Currency

NLG / /

/

Facility

Erasmus University / Hospital St. Antoniushove / University Hospital St. Radboud / Blauw Call Centre / /

/

IndustryTerm

treatment of erectile dysfunction / therapy for erectile dysfunction / public health insurance / /

MarketIndex

VALUATION OF INTERNATIONAL / /

MedicalCondition

moderate impotence / disorder / OF ERECTILE DYSFUNCTION / erectile dysfunction / complete erectile dysfunction / /

MedicalTreatment

oral therapy / relaxation / /

Organization

Sick Fund / European Agency for the Evaluation of Medicinal Products / Erasmus University Rotterdam / Blauw Call Centre Rotterdam / Institute for Medical Technology / European Union / Institute for Medical Technology Assessment / /

Person

Lianne Damen / Paul Rabsztyn / Jan van Busschbach Rotterdam / /

/

Position

General / nurse scientist / Corresponding author / /

Product

Viagra / /

SocialTag